Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
Investigating the Dynamics of Patient Engagement and Trends in Participation in Recurrent Prostate Cancer Clinical Trials
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at trial experiences for adults with prostate cancer that has come back. It examines how safe new treatments are and how well they work compared with standard treatments. It also looks for patterns across different groups of patients to help future patients.
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are at least 18 years old.
- You have prostate cancer that has come back.
- You can understand and are willing to sign a form agreeing to join the study.
Who can't join
- You are in another research study.
- You have a mental health condition or life situation that would make it hard to follow study requirements.
- You cannot give written consent to join the study.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Patient is at least 18 years of age * Diagnosis of recurrent prostate cancer * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Enrolled in another research study * Patients with psychiatric illness/social situations that would limit compliance with study requirements * Inability to provide written informed consent
Study sites (1)
CA
- Power Life Sciences · San Francisco, CA 94107Michael B Gill · Study contact · 415-900-4227 · https://www.withpower.com/contact-us@withpower.comMore trials in San Francisco